Cozar, J. M., Solsona, E., Morote, J., Minana, B., Maroto, J. P., Gonzalez del Alba, A., Climent, M. A., Carles, J., Alcaraz, A., Castellano, D. (2012).
Recomendations on the Management of Controversies in Advanced Castrate-Resistant Prostate Cancer
ACTAS UROLOGICAS ESPANOLAS. Article. 36(10):569-577.
[doi:10.1016/j.acuro.2012.06.004]
Agudo-Lopez, A., Perez, C., Diaz-Garcia, C. V., del Solar, V., Aleman, J., Agullo-Ortuno, M. T., Cortes-Funes, H., Navarro-Ranninger, C., Lopez-Martin, J. A. (2012).
Mechanistic Differences Between a New Platinum(II) Mono-sulphonamide and Cisplatin in Melanoma Cell Lines
EUROPEAN JOURNAL OF CANCER. Meeting Abstract. 48(6):56-56.
[doi:10.1016/S0959-8049(12)71984-6]
Gauler, T. C., Clement, P. M., Peyrade, F., Krauss, J., Mesia, R., Remenar, E., Keilholz, U., Delord, J. P., Schafhausen, P., Erfan, J., Brummendorf, T. H., Iglesias, L., Bethe, U., Hicking, C., Vermorken, J. B., ADVANTAGE Trial Grp (2012).
Cilengitide with cetuximab, cisplatin, and 5-FU in recurrent and/or metastatic squamous cell cancer of the head and neck: the phase II ADVANTAGE trial
ONKOLOGIE. Meeting Abstract. 35(6):193-194.
Sepulveda Sanchez, J., Farfan, C., Villacampa, F., Velasco, G., Benitez, J., Rodriguez, C., Calderon, M., Canamares, I., Cortes-Funes, H., Castellano, D. E. (2012).
GENETIC POLYMORPHISMS AND SUNITINIB TOXICITY IN METASTATIC RENAL-CELL CARCINOMA
ANNALS OF ONCOLOGY. Meeting Abstract. 23(9):281-282.
Castellano, Daniel, Antonio Virizuela, Juan, Cruz, Josefina, Manuel Sepulveda, Juan, Saenz, Maribel, Paz-Ares, Luis (2012).
The role of pharmacogenomics in metastatic renal cell carcinoma
CANCER AND METASTASIS REVIEWS. Review. 31(1):29-32.
[doi:10.1007/s10555-012-9356-x]
Castellano, Daniel, Bellmunt, Joaquim (2012).
The optimize project: beyond first-line therapy in metastatic renal cell carcinoma
CANCER AND METASTASIS REVIEWS. Editorial Material. 31(1):1-2.
[doi:10.1007/s10555-012-9393-5]
Pardo, Beatriz, Salazar, Ramon, Ciruelos, Eva, Cortes-Funes, Hernan, Garcia, Margarita, Majem, Margarita, Montes, Ana, Cuadra, Carmen, Soto-Matos, Arturo, Lebedinsky, Claudia, Alfaro, Vicente, Paz-Ares, Luis (2012).
Phase I and pharmacokinetic study of trabectedin 3-hour infusion every three weeks in patients with advanced cancer and alteration of hepatic function
MEDICAL ONCOLOGY. Article. 29(3):2240-2250.
[doi:10.1007/s12032-011-9979-8]
Laquente, B., Capdevila, J., Martinez-Villacampa, M., Lopez, C., Safont, M. J., Gomez, A., Manzano, J. L., Gravalos, C., Salazar, R., Aranda Aguilar, E. (2012).
NEOADJUVANT ADDITION OF BEVACIZUMAB TO CHEMORADIATION IN RECTAL CANCER: IMPACT ON ANGIOGENIC BIOMARKERS
ANNALS OF ONCOLOGY. Meeting Abstract. 23(9):529-529.
Lopez Martin, J. A., Gonzalez Cao, M., Sereno, M., Mayordomo, J., Hidalgo, M., Campos, B., Cumplido, D., Zambrana, F., Medina, J., Berrocal, A. (2012).
IPILIMUMAB IN OLDER PATIENTS: SPANISH MELANOMA MULTIDISCIPLINARY GROUP (GEM) EXPERIENCE IN THE EXPANDED ACCESS PROGRAMME
ANNALS OF ONCOLOGY. Meeting Abstract. 23(9):374-375.
Castellano, D. E., Anton Aparicio, L. M., Esteban, E., Velasco, G., Perez, Q., Sanchez, A., Perez-Valderrama, B., Batista, N. (2012).
CABAZITAXEL IN PATIENTS WITH ADVANCED CRPC AFTER DOCETAXEL-FAILURE. RESULTS OF EXPANDED PROGRAM ACCESS (EAP) IN SPAIN: SAFETY AND EFFICACY
ANNALS OF ONCOLOGY. Meeting Abstract. 23(9):314-314.
Rodriguez-Moreno, J. F., Esteban, E., Morente, M., Alemany, I., Castellano, D. E., Gonzalez Del Alba, A., Climent, M., Rodriguez-Antona, C., Garcia-Donas, J. (2012).
TISSUE MICROARRAY (TMA) AND VHL MUTATIONS AS PREDICTORS OF OUTCOME IN ADVANCED CLEAR CELL RENAL CELL CARCINOMA (CCRCC) TREATED WITH FIRS LINE SUNITINIB
ANNALS OF ONCOLOGY. Meeting Abstract. 23(9):276-276.
Carles, J., Bellmunt, J., Maroto, P., Font, A., Morales-Barrera, R., Suarez, C., Martin Lorente, C., Etxaniz, O., Capdevila, L., Castellano, D. E. (2012).
PHASE II CLINICAL AND PHARMACOKINETIC (PK) TRIAL OF ZALYPSIS (Z) IN PATIENTS WITH UROTHELIAL CARCINOMA (UC) PROGRESSING AFTER A FIRST-LINE PLATINUM-BASED REGIMEN
ANNALS OF ONCOLOGY. Meeting Abstract. 23(9):266-266.
Miles, D., Peretz-Yablonski, T., Ciruelos, E., Puglisi, F., Schneeweiss, A., Mitchell, L., Duenne, A., Bachelot, T. (2012).
PERTUZUMAB IN COMBINATION WITH TRASTUZUMAB AND A TAXANE FOR THE FIRST-LINE TREATMENT OF PATIENTS WITH HER2-POSITIVE ADVANCED BREAST CANCER: A SINGLE ARM PHASE IIIB STUDY (PERUSE)
ANNALS OF ONCOLOGY. Meeting Abstract. 23(9):142-143.
Pascual, T., Ciruelos, E., Manso, L., Ghanem, I., Manneh, R. A., Mendiola, C., Lora, D., Cortes-Funes, H. (2012).
RESPONSE TO NEOADJUVANT THERAPY AND DISEASE FREE SURVIVAL AND OVERALL SURVIVAL IN PATIENTS WITH TRIPLE-NEGATIVE BREAST CANCER (TNBC): SINGLE CENTER EXPERIENCE
ANNALS OF ONCOLOGY. Meeting Abstract. 23(9):134-134.
Ciruelos, E., De Velasco, G. A., Gamez, A., Castaneda, C., Sepulveda, J., Ghanem, I., Cortes-Funes, H., Fresno, J. A. (2012).
CLINICAL SIGNIFICANCE OF MICRORNA EXPRESSION AS A PROGNOSTIC FACTOR IN EARLY N plus BREAST CANCER (BC)
ANNALS OF ONCOLOGY. Meeting Abstract. 23(9):96-96.
Manso, L., Perez-Carrion, R., Chacon Lopez-Muniz, J. I., Garcia Palomo, A., Galve Calvo, E., Llorente, R. M., Casinello, J., Catalan, G., Llorca, C., Gravalos, C. (2012).
PROGNOSTIC FACTORS INFLUENCING THE SELECTION OF BEVACIZUMAB COMBINED WITH CHEMOTHERAPY IN PATIENTS WITH HER2-NEGATIVE METASTATIC BREAST CANCER IN ROUTINE CLINICAL PRACTICE. ONCOSUR-AVALOX: OBSERVATIONAL CROSS-SECTIONAL STUDY
ANNALS OF ONCOLOGY. Meeting Abstract. 23(9):125-125.
Mendiola, C., Davidenko, I., Colombo, N., Korach, J., Selle, F., Gocze, P., Chmielowska, E., Pautier, P., Bollag, D., Oza, A. M. (2012).
ROSIA: A SINGLE-ARM STUDY IN MORE THAN 1000 PATIENTS (PTS) RECEIVING FRONT-LINE BEVACIZUMAB (BEV) plus CHEMOTHERAPY (CT) FOR OVARIAN CANCER (OC)
ANNALS OF ONCOLOGY. Meeting Abstract. 23(9):322-323.
Duenas, Marta, Santos, Mirentxu, Aranda, Juan F., Bielza, Concha, Martinez-Cruz, Ana B., Lorz, Corina, Taron, Miquel, Ciruelos, Eva M., Rodriguez-Peralto, Jose L., Martin, Miguel, Larranaga, Pedro, Dahabreh, Jubrail, Stathopoulos, George P., Rosell, Rafael, Paramio, Jesus M., Garcia-Escudero, Ramon (2012).
Mouse p53-Deficient Cancer Models as Platforms for Obtaining Genomic Predictors of Human Cancer Clinical Outcomes
PLOS ONE. Article. 7(8).
[doi:10.1371/journal.pone.0042494]
Castellano, Daniel, Carles, Joan, Esteban, Emilio, Manuel Trigo, Jose, Angel Climent, Miguel, Pablo Maroto, Jose, Garcia del Muro, Xavier, Font, Albert, Paz-Ares, Luis, Angel Arranz, Jose, Bellmunt, Joaquim (2012).
Recommendations for the optimal management of early and advanced urothelial carcinoma
CANCER TREATMENT REVIEWS. Review. 38(5):431-441.
[doi:10.1016/j.ctrv.2011.10.004]
Gravalos, Cristina, Salut, Antonieta, Garcia-Giron, Carlos, Garcia-Carbonero, Rocio, Isabel Leon, Ana, Sevilla, Isabel, Maurel, Joan, Esteban, Beatriz, Garcia-Rico, Eduardo, Murias, Adolfo, Cortes-Funes, Hernan (2012).
A randomized phase II study to compare oxaliplatin plus 5-fluorouracil and leucovorin (FOLFOX4) versus oxaliplatin plus raltitrexed (TOMOX) as first-line chemotherapy for advanced colorectal cancer
CLINICAL & TRANSLATIONAL ONCOLOGY. Article. 14(8):606-612.
[doi:10.1007/s12094-012-0843-x]
Rivera, Fernando, Gravalos, Cristina, Garcia-Carbonero, Rocio (2012).
SEOM clinical guidelines for the diagnosis and treatment of gastric adenocarcinoma
CLINICAL & TRANSLATIONAL ONCOLOGY. Article. 14(7):528-535.
[doi:10.1007/s12094-012-0836-9]
Martin Cristina, Gastalver, Susana, CC, Chicharro Natalia, De Amuriza, Aguilella Vizcaino, Ma J., Maria Puy, Goyache Goni, Herreros de Tejada, A. (2012).
ANALYSIS OF PANITUMUMAB USE IN THE CLINICAL PRACTICE
ATENCION FARMACEUTICA. Article. 14(4):270-275.
Ponce Aix, S., Enguita Valls, A. B., Iglesias Docampo, L. C., Nunez Sobrino, J. A., Vega Alonso, E., Dorta Suarez, M., Hoyos, S., Cortes-Funes, H., Rodriguez Peralto, J. L. (2012).
SYSTEMATIC DETERMINATION OF EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) MUTATION STATUS IN PATIENTS WITH NEWLY NON SMALL CELL LUNG CANCER (NSCLS): ONE YEAR EXPERIENCE OF A SINGLE CENTER
JOURNAL OF THORACIC ONCOLOGY. Meeting Abstract. 7(6, S):35-35.
Espinosa, E., Gamez-Pozo, A., Sanchez-Navarro, I., Pinto, A., Castaneda, C. A., Ciruelos, E., Feliu, J., Fresno Vara, J. A. (2012).
The present and future of gene profiling in breast cancer
CANCER AND METASTASIS REVIEWS. Review. 31(1-2):41-46.
[doi:10.1007/s10555-011-9327-7]
Garcia Alfonso, Pilar, Chaves, Manuel, Munoz, Andres, Salud, Antonieta, Garcia-Giron, Carlos, Gravalos, Cristina, Massuti, Bartomeu, Gonzalez-Flores, Encarnacion, Queralt, Bernardo, Lopez-Ladron, Amelia, Losa, Ferran, Oltra, Amparo, Jose Gomez, Ma, Manuel Campos, J., Aranda, Enrique (2012).
PHASE II STUDY TO EVALUATE EFFICACY AND SAFETY OF IRINOTECAN, CAPECITABINE AND BEVACIZUMAB IN METASTATIC COLORECTAL CANCER (MCRC) PATIENTS
ANNALS OF ONCOLOGY. Meeting Abstract. 23(4):103-104.
Gravalos, Cristina, Salvador, Javier, Albanell, Joan, Barnadas, Agustin, Borrega, Pablo, Garcia-Mata, Jesus, Garrido, Pilar, Gonzalez-Flores, Encarnacion, Isla, Dolores, Lomas, Maria, Rodriguez-Lescure, Alvaro, Jesus Cruz, Juan, Alba, Emilio, Spanish Soc Med Oncology SEOM (2012).
Functions and workload of medical oncologists in Spain
CLINICAL & TRANSLATIONAL ONCOLOGY. Article. 14(6):423-429.
[doi:10.1007/s12094-012-0819-x]
Alcaraz, A., Medina, R., Maroto, P., Climent, M. A., Castellano, D., Carles, J. (2012).
Castration-Resistant Prostate Cancer: Where are We Going?
ACTAS UROLOGICAS ESPANOLAS. Review. 36(6):367-374.
[doi:10.1016/j.acuro.2011.10.010]
Garcia-Velasco, Adelaida, Duran, Ignacio, Garcia, Elena, Taron, Miquel, Ballestin, Claudio, Castellanos, Daniel, Cortes-Funes, Hernan, Paz-Ares, Luis (2012).
Biological markers of cisplatin resistance in advanced testicular germ cell tumours
CLINICAL & TRANSLATIONAL ONCOLOGY. Article. 14(6):452-457.
[doi:10.1007/s12094-012-0823-1]
Castaneda, Carlos A., Andres, Eva, Barcena, Carmen, Gomez, Henry L., Cortes-Funes, Hernan, Ciruelos, Eva (2012).
Behaviour of breast cancer molecular subtypes through tumour progression
CLINICAL & TRANSLATIONAL ONCOLOGY. Article. 14(6):481-485.
[doi:10.1007/s12094-012-0827-x]
Baselga, Jose, Martins Segalla, Jose Getulio, Roche, Henri, del Giglio, Auro, Pinczowski, Helio, Ciruelos, Eva M., Cabral Filho, Sebastiao, Gomez, Patricia, Van Eyll, Brigitte, Bermejo, Begona, Llombart, Antonio, Garicochea, Bernardo, Climent Duran, Miguel Angel, Gehm Hoff, Paulo Marcelo, Espie, Marc, Junior Gemeinder de Moraes, Andre Augusto, Ribeiro, Ronaldo Albuquerque, Mathias, Clarissa, Gil Gil, Miguel, Ojeda, Belen, Morales, Josefa, Ro, Sunhee Kwon, Li, Shell, Costa, Frederico (2012).
Sorafenib in Combination With Capecitabine: An Oral Regimen for Patients With HER2-Negative Locally Advanced or Metastatic Breast Cancer
JOURNAL OF CLINICAL ONCOLOGY. Article. 30(13):1484-1491.
[doi:10.1200/JCO.2011.36.7771]
Yap, T. A., Cortes-Funes, H., Shaw, H., Rodriguez, R., Olmos, D., Lal, R., Fong, P. C., Tan, D. S., Harris, D., Capdevila, J., Coronado, C., Alfaro, V., Soto-Matos, A., Fernandez-Teruel, C., Siguero, M., Tabernero, J. M., Paz-Ares, L., de Bono, J. S., Lopez-Martin, J. A. (2012).
First-in-man phase I trial of two schedules of the novel synthetic tetrahydroisoquinoline alkaloid PM00104 (Zalypsis) in patients with advanced solid tumours
BRITISH JOURNAL OF CANCER. Article. 106(8):1379-1385.
[doi:10.1038/bjc.2012.99]
Zambetti, Milvia, Mansutti, Mauro, Gomez, Patricia, Lluch, Ana, Dittrich, Christian, Zamagni, Claudio, Ciruelos, Eva, Pavesi, Lorenzo, Semiglazov, Vladimir, De Benedictis, Elena, Gaion, Fernando, Bari, Mario, Morandi, Paolo, Valagussa, Pinuccia, Luca, Gianni (2012).
Pathological complete response rates following different neoadjuvant chemotherapy regimens for operable breast cancer according to ER status, in two parallel, randomized phase II trials with an adaptive study design (ECTO II)
BREAST CANCER RESEARCH AND TREATMENT. Article. 132(3, SI):843-851.
[doi:10.1007/s10549-011-1660-6]
Hitt, R., Irigoyen, A., Cortes-Funes, H., Grau, J. J., Garcia-Saenz, J. A., Cruz-Hernandez, J. J., Spanish Head Neck Canc Cooperative (2012).
Phase II study of the combination of cetuximab and weekly paclitaxel in the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of head and neck
ANNALS OF ONCOLOGY. Article. 23(4):1016-1022.
[doi:10.1093/annonc/mdr367]
Paz-Ares, Luis, Lopez-Pousa, Antonio, Poveda, Andres, Balana, Carmen, Ciruelos, Eva, Bellmunt, Joaquim, Garcia del Muro, Javier, Provencio, Mariano, Casado, Antonio, Rivera-Herrero, Fernando, Izquierdo, Miguel Angel, Nieto, Antonio, Tanovic, Adnan, Cortes-Funes, Hernan, Maria Buesa, Jose (2012).
Trabectedin in pre-treated patients with advanced or metastatic soft tissue sarcoma: a phase II study evaluating co-treatment with dexamethasone
INVESTIGATIONAL NEW DRUGS. Article. 30(2):729-740.
[doi:10.1007/s10637-010-9561-9]
Capdevila, Jaume, Iglesias, Lara, Halperin, Irene, Segura, Angel, Martinez-Trufero, Javier, Angeles Vaz, Maria, Corral, Jesus, Obiols, Gabriel, Grande, Enrique, Jose Grau, Juan, Tabernero, Josep (2012).
Sorafenib in metastatic thyroid cancer
ENDOCRINE-RELATED CANCER. Article. 19(2):209-216.
[doi:10.1530/ERC-11-0351]
Gamez-Pozo, Angelo, Sanchez-Navarro, Iker, Calvo, Enrique, Teresa Agullo-Ortuno, Maria, Lopez-Vacas, Rocio, Diaz, Esther, Camafeita, Emilio, Nistal, Manuel, Madero, Rosario, Espinosa, Enrique, Antonio Lopez, Juan, Fresno Vara, Juan Angel (2012).
PTRF/Cavin-1 and MIF Proteins Are Identified as Non-Small Cell Lung Cancer Biomarkers by Label-Free Proteomics
PLOS ONE. Article. 7(3).
[doi:10.1371/journal.pone.0033752]
Tortorici, M. A., Iglesias, L., Kozloff, M. F., Pithavala, Y. K., Ingrosso, A., Belani, C. P. (2012).
PHARMACOKINETIC (PK) ANALYSIS OF COADMINISTRATION OF AXITINIB AND PEMETREXED/CISPLATIN (PEM/CIS) IN PATIENTS WITH NON-SMALL CELL LUNG CANCER (NSCLC).
CLINICAL PHARMACOLOGY & THERAPEUTICS. Meeting Abstract. 91(1):33-33.
Vinik, Aaron, Van Cutsem, Eric, Niccoli, Patricia, Raoul, Jean-Luc, Bang, Yung-Jue, Borbath, Ivan, Lombard-Bohas, Catherine, Valle, Juan W., Metrakos, Peter, Smith, Denis, Chen, Jen-Shi, Hoersch, Dieter, Castellano, Daniel E., Kennecke, Hagen F., Picus, Joel, Van Hazel, Guy, Patyna, Shem, Lu, Dongrui Ray, Chao, Richard C., Raymond, Eric (2012).
Progression-Free Survival (PFS) by Blinded Independent Central Review (BICR) and Updated Overall Survival (OS) of Sunitinib versus Placebo for Patients with Progressive, Unresectable, Well Differentiated Pancreatic Neuroendocrine Tumor (NET)
Pancreas. Meeting Abstract. 41(2):350-350.
Cortes, Javier, Caralt, Mireia, Delaloge, Suzette, Cortes-Funes, Hernan, Pierga, Jean-Yves, Pritchard, Kathleen I., Bollag, David T., Miles, David W. (2012).
Safety of bevacizumab in metastatic breast cancer patients undergoing surgery
EUROPEAN JOURNAL OF CANCER. Article. 48(4):475-481.
[doi:10.1016/j.ejca.2011.11.021]
Sastre, Javier, Gravalos, Cristina, Rivera, Fernando, Massuti, Bartomeu, Valladares-Ayerbes, Manuel, Marcuello, Eugenio, Manzano, Jose L., Benavides, Manuel, Hidalgo, Manuel, Diaz-Rubio, Eduardo, Aranda, Enrique (2012).
First-Line Cetuximab Plus Capecitabine in Elderly Patients with Advanced Colorectal Cancer: Clinical Outcome and Subgroup Analysis According to KRAS Status from a Spanish TTD Group Study
ONCOLOGIST. Article. 17(3):339-345.
[doi:10.1634/theoncologist.2011-0406]
Alba, E., Ciruelos, E., Lopez, R., Lopez Vega, J. M., Lluch, A., Martin, M., Sanchez Rovira, P., Segui, M. A., Rubio Liria, M., Perez, F. (2012).
A Spanish Cost-utility Analysis of Nab-paclitaxel Compared to Conventional Paclitaxel Monotherapy for Pretreated Metastatic Breast Cancer: Results From the COSTABRAX Study
EUROPEAN JOURNAL OF CANCER. Meeting Abstract. 48(1):117-117.
Carles, Joan, Castellano, Daniel, Angel Climent, Miguel, Maroto, Pablo, Medina, Rafael, Alcaraz, Antonio (2012).
Castration-resistant metastatic prostate cancer: current status and treatment possibilities
CLINICAL & TRANSLATIONAL ONCOLOGY. Article. 14(3):169-176.
[doi:10.1007/s12094-012-0780-8]
Wolin, Edward, Castellano, Daniel, Kaltsas, Gregory, Gross, David, Panneerselvam, Ashok, Klimovsky, Judith, Saletan, Stephen, Yao, James, Baudin, Eric (2012).
Correlation of Progression-Free Survival (PFS) with Early Response of Biomarkers Chromogranin A (CgA) and 5-Hhydroxyindoleacetic Acid (5-HIAA) Levels in Patients with Advanced Neuroendocrine Tumors: Phase III RADIANT-2 Study Results
Pancreas. Meeting Abstract. 41(2):350-351.
Alonso, Vicente, Marmol, Maribel, Castellano, Daniel, Fonseca, Emilio, Velasco, Amalia, Garcia Lopez, Jose Luis, Pineda, Eva, Maisonobe, Pascal, Massuti, Bertomeu, Martin-Richard, Marta, TTD Study Grp (2012).
Evaluation of the Efficacy and Safety of Lanreotide on Tumor Growth Stabilization in Patients with Progressive NETs Who Are Not Eligible for Treatment with Surgery or Chemotherapy
Pancreas. Meeting Abstract. 41(2):342-342.
Baselga, Jose, Bradbury, Ian, Eidtmann, Holger, Di Cosimo, Serena, de Azambuja, Evandro, Aura, Claudia, Gomez, Henry, Dinh, Phuong, Fauria, Karine, Van Dooren, Veerle, Aktan, Gursel, Goldhirsch, Aron, Chang, Tsai-Wang, Horvath, Zsolt, Coccia-Portugal, Maria, Domont, Julien, Tseng, Ling-Min, Kunz, Georg, Sohn, Joo Hyuk, Semiglazov, Vladimir, Lerzo, Guillermo, Palacova, Marketa, Probachai, Volodymyr, Pusztai, Lajos, Untch, Michael, Gelber, Richard D., Piccart-Gebhart, Martine, NeoALTTO Study Team (2012).
Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial
LANCET. Article. 379(9816):633-640.
[doi:10.1016/S0140-6736(11)61847-3]
Gruenwald, Viktor, Karakiewicz, Pierre I., Bavbek, Sevil E., Miller, Kurt, Machiels, Jean-Pascal, Lee, Se-Hoon, Larkin, James, Bono, Petri, Rha, Sun Young, Castellano, Daniel, Blank, Christian U., Knox, Jennifer J., Hawkins, Robert, Anak, Oezlem, Rosamilia, Marianne, Booth, Jocelyn, Pirotta, Nicoletta, Bodrogi, Istvan, REACT Study Grp (2012).
An international expanded-access programme of everolimus: Addressing safety and efficacy in patients with metastatic renal cell carcinoma who progress after initial vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapy
EUROPEAN JOURNAL OF CANCER. Article. 48(3):324-332.
[doi:10.1016/j.ejca.2011.06.054]
Baselga, Jose, Cortes, Javier, Kim, Sung-Bae, Im, Seock-Ah, Hegg, Roberto, Im, Young-Hyuck, Roman, Laslo, Pedrini, Jose Luiz, Pienkowski, Tadeusz, Knott, Adam, Clark, Emma, Benyunes, Mark C., Ross, Graham, Swain, Sandra M., CLEOPATRA Study Grp (2012).
Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer
NEW ENGLAND JOURNAL OF MEDICINE. Article. 366(2):109-119.
[doi:10.1056/NEJMoa1113216]
Thomssen, Christoph, Pierga, Jean-Yves, Pritchard, Kathleen I., Biganzoli, Laura, Cortes-Funes, Hernan, Petrakova, Katarina, Kaufman, Bella, Duenne, Anja, Smith, Ian (2012).
First-Line Bevacizumab-Containing Therapy for Triple-Negative Breast Cancer: Analysis of 585 Patients Treated in the ATHENA Study
ONCOLOGY. Article. 82(4):218-227.
[doi:10.1159/000336892]
Rodriguez Antolin, Alfredo, Duarte Ojeda, Jose Manuel, Romero Otero, Javier, Cabeza Rodriguez, Angeles, Castellano, Daniel, Dominguez Esteban, Mario, Diez Sicilia, Laura, Diaz Gonzalez, Rafael (2012).
Hormonal treatment in biochemical recurrence after radical prostatectomy
ARCHIVOS ESPANOLES DE UROLOGIA. Article. 65(1):111-121.
